In the BioHarmony Drug Report Database

"Preview" Icon

Peramivir

Rapivab (peramivir) is a small molecule pharmaceutical. Peramivir was first approved as Rapivab on 2014-12-19. It is used to treat human influenza in the USA. Rapivab’s patents are valid until 2027-05-07 (FDA).

 

Trade Name

 

Rapivab
 

Common Name

 

peramivir
 

ChEMBL ID

 

CHEMBL139367
 

Indication

 

human influenza
 

Drug Class

 

Antivirals: neuraminidase inhibitors

Image (chem structure or protein)

Peramivir structure rendering